The BioFabUSA program is a public-private partnership between the Department of Defense (DoD) and the Advanced Regenerative Manufacturing Institute (ARMI), a member-driven, nonprofit organization whose mission is to make practical the scalable, consistent and cost-effective manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.
Within the last decade, significant breakthroughs in cell biology, biofabrication and materials science have laid the foundation for the large-scale manufacturing and commercialization of engineered tissues. However, the field of tissue engineering remains fragmented and lacks a mechanistic framework through which to translate laboratory discovery into manufactured products.
The goal of the institute is to close the gap in focus that inhibits the commercialization and translation of research and development. By removing existing regulatory hurdles, producing scalable, GMP-compliant processes, and establishing a commercial ecosystem, ARMI will help catalyze and foster the development of a new industry.
Company Details
- Employees
- 106
- Founded
- -
- Address
- 400 Commercial St, Manchester,new Hampshire 03101,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- armiusa.org
- Keywords
- biofabrication, regenerative manufacturing, biotechnology, manufacturing, tissue engineering, biomedical engineering, regenerative medicine.
- HQ
- Manchester, New Hampshire
- Competitors
- NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals, Lonza, Safi Biotherapeutics Inc, FIRST, United Therapeutics Corporation, NH Life Sciences, PRO Therapeutics, DEKA Research & Development, Vertex Pharmaceuticals, NextGen Manchester: NH Biofabrication Cluster.
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa Questions
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa's website is armiusa.org
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa's LinkedIn profile is https://www.linkedin.com/company/armiusa
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa has
106 employees.
View email and phone details for 106
employees at Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa.
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa's industry is
Biotechnology Research
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa's top competitors are
Niimbl | The National Institute For Innovation In Manufacturing Biopharmaceuticals,
Lonza,
Safi Biotherapeutics Inc,
First,
United Therapeutics Corporation,
Nh Life Sciences,
Pro Therapeutics,
Deka Research & Development,
Vertex Pharmaceuticals,
Nextgen Manchester: Nh Biofabrication Cluster.
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa's categories are Biotechnology Research
Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa's founding year is 2016
